InvestWiser

Arcoma AB

ARCOMANasdaq StockholmHealthcareMarket value 109 m SEK
7.64SEK −4.0%
last day · Price as of 17 November 2026

The answer first

Does Arcoma beat the market?

No, Arcoma has not beaten the market over the last year.

Arcoma+4.4%Stockholm (OMXSGI)+18.7%
  • The ranking · Quality, value and trend combined

    Better than 74% of Nordic stocks

    • Quality81
    • Value75
    • Trend33

    No. 30 of 195 in healthcare

  • Expectations in the price

    Low expectations

    For the share to return about 9% a year from today's price, it is enough that the cash Arcoma keeps shrinks about 3% a year for 10 years.

Max for seven days

Follow Arcoma with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 17 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Arcoma

From today, at a price of 7.64 SEK. Write why you follow Arcoma, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Arcoma

Your first answer is free, no account needed.

Do you own Arcoma, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Arcoma and a few more. Free, no card.

Past year against the exchange and Super Stock
Arcoma+4.4%Stockholm (OMXSGI)+18.7%Super Stock+45.9%
14 November 202517 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Arcoma has risen 4.4% over the past year, including dividends.
  • Overall, Arcoma ranks better than 74% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 72.5%. The price is 70.2% below its peak now.

What do analysts think of Arcoma?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

74

Quality, value and trend together. Better than 74% of Nordic stocks.

No. 30 of 195 in healthcare

Quality81
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 50 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns1.30
  • Return on equityProfit divided by equity+6.2%
  • Cash conversionOperating cash flow divided by profit2.49

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value75
The price · Valuation: the multiples

High Low price: you pay little for what the company earns and owns.

No. 16 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity1.4
  • P/SPrice divided by sales0.9
  • P/EPrice divided by earnings22.2
  • P/CFPrice divided by operating cash flow8.9

The ranking is built on P/E, P/B and P/S.

Trend33
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 103 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−9.9%
  • 6 months−18.6%
  • 9 months−8.0%
  • 12 months+4.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+2.7%
3 years, per year
−1.1%
5 years, per year
−9.7%
10 years, per year
+6.2%
Largest fall, 3 years
−72.5%
From a peak to the bottom
From the peak now
−70.2%
How far the price is from the peak
Volatility, 1 year
56.5%
How much the price swings over a year
Beta, 1 year
0.20
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Arcoma

One fund we follow owns Arcoma. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About Arcoma

Arcoma AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 31 employees.

Arcoma AB (publ) develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanced remote control, form pad, hand control, compression belt, detector holder, foot control, lateral armrest, patient handgrip, mattress, scatter correction software, battery charger, battery pack, and stitching screen.

See the full analysis of Arcoma.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market